NO20051089L - Bredspektrede 2-amino-benzotiazol-sulfonamid-HIV-proteaseinhibitorer - Google Patents
Bredspektrede 2-amino-benzotiazol-sulfonamid-HIV-proteaseinhibitorerInfo
- Publication number
- NO20051089L NO20051089L NO20051089A NO20051089A NO20051089L NO 20051089 L NO20051089 L NO 20051089L NO 20051089 A NO20051089 A NO 20051089A NO 20051089 A NO20051089 A NO 20051089A NO 20051089 L NO20051089 L NO 20051089L
- Authority
- NO
- Norway
- Prior art keywords
- alkyl
- amino
- hiv protease
- benzothiazole
- spectrum
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D277/82—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- AIDS & HIV (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02078231 | 2002-08-02 | ||
| US42786202P | 2002-11-20 | 2002-11-20 | |
| PCT/EP2003/050359 WO2004014371A1 (en) | 2002-08-02 | 2003-08-04 | Broadspectrum 2-amino-benzothiazole sulfonamide hiv protease inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20051089L true NO20051089L (no) | 2005-05-02 |
Family
ID=31716850
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20051089A NO20051089L (no) | 2002-08-02 | 2005-03-01 | Bredspektrede 2-amino-benzotiazol-sulfonamid-HIV-proteaseinhibitorer |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US20050267156A1 (ru) |
| EP (1) | EP1545518A1 (ru) |
| KR (1) | KR20050025647A (ru) |
| CN (1) | CN1671380B (ru) |
| AP (1) | AP1878A (ru) |
| AU (1) | AU2003262561B2 (ru) |
| BR (1) | BR0305717A (ru) |
| CA (1) | CA2492832C (ru) |
| EA (1) | EA008594B1 (ru) |
| HR (1) | HRP20050605A2 (ru) |
| IL (1) | IL166257A (ru) |
| MX (1) | MXPA05001275A (ru) |
| NO (1) | NO20051089L (ru) |
| NZ (1) | NZ538488A (ru) |
| PL (1) | PL374948A1 (ru) |
| WO (1) | WO2004014371A1 (ru) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2566340C (en) * | 2004-05-07 | 2014-05-06 | Sequoia Pharmaceuticals, Inc. | Resistance-repellent retroviral protease inhibitors |
| JO2841B1 (en) * | 2006-06-23 | 2014-09-15 | تيبوتيك فارماسيوتيكالز ليمتد | 2-(substituted-amino) -benzothiazole sulfonamide as protease inhibitors HIV (HIV) |
| US8267163B2 (en) * | 2008-03-17 | 2012-09-18 | Visteon Global Technologies, Inc. | Radiator tube dimple pattern |
| WO2011061590A1 (en) | 2009-11-17 | 2011-05-26 | Hetero Research Foundation | Novel carboxamide derivatives as hiv inhibitors |
| MX2012015097A (es) | 2010-07-02 | 2013-05-28 | Gilead Sciences Inc | Derivados de acido naft-2-ilacetico para tratar sida. |
| TWI458711B (zh) | 2010-07-02 | 2014-11-01 | Gilead Sciences Inc | 治療性化合物 |
| US9024038B2 (en) | 2010-12-27 | 2015-05-05 | Purdue Research Foundation | Compunds and methods for treating HIV |
| MX2013012266A (es) | 2011-04-21 | 2013-11-22 | Gilead Sciences Inc | Compuestos de benzotiazol y su uso farmaceutico. |
| WO2013103738A1 (en) | 2012-01-04 | 2013-07-11 | Gilead Sciences, Inc. | Napthalene acetic acid derivatives against hiv infection |
| US9376392B2 (en) | 2012-01-04 | 2016-06-28 | Gilead Sciences, Inc. | 2-(tert-butoxy)-2-(7-methylquinolin-6-yl) acetic acid derivatives for treating AIDS |
| SG11201401189WA (en) | 2012-04-20 | 2014-09-26 | Gilead Sciences Inc | Benzothiazol- 6 -yl acetic acid derivatives and their use for treating an hiv infection |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5968942A (en) * | 1992-08-25 | 1999-10-19 | G. D. Searle & Co. | α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| ES2127938T3 (es) * | 1993-08-24 | 1999-05-01 | Searle & Co | Hidroxietilamino sulfonamidas utiles como inhibidores de proteasas retroviricas. |
| AU4828199A (en) * | 1998-06-23 | 2000-01-10 | Board Of Trustees Of The University Of Illinois, The | Multi-drug resistant retroviral protease inhibitors and associated methods |
| ATE343567T1 (de) * | 2001-02-14 | 2006-11-15 | Tibotec Pharm Ltd | Breitspektrum 2-(substituierte-amino)- benzothiazol-sulfonamide hiv protease inhibitoren |
-
2003
- 2003-08-04 EP EP03784205A patent/EP1545518A1/en not_active Ceased
- 2003-08-04 WO PCT/EP2003/050359 patent/WO2004014371A1/en active Application Filing
- 2003-08-04 CA CA2492832A patent/CA2492832C/en not_active Expired - Fee Related
- 2003-08-04 MX MXPA05001275A patent/MXPA05001275A/es active IP Right Grant
- 2003-08-04 AP AP2005003242A patent/AP1878A/xx active
- 2003-08-04 NZ NZ538488A patent/NZ538488A/en not_active IP Right Cessation
- 2003-08-04 EA EA200500298A patent/EA008594B1/ru not_active IP Right Cessation
- 2003-08-04 US US10/523,445 patent/US20050267156A1/en not_active Abandoned
- 2003-08-04 BR BR0305717-8A patent/BR0305717A/pt not_active Application Discontinuation
- 2003-08-04 PL PL03374948A patent/PL374948A1/xx not_active Application Discontinuation
- 2003-08-04 KR KR1020057001206A patent/KR20050025647A/ko not_active Application Discontinuation
- 2003-08-04 CN CN038184044A patent/CN1671380B/zh not_active Expired - Fee Related
- 2003-08-04 AU AU2003262561A patent/AU2003262561B2/en not_active Ceased
-
2005
- 2005-01-12 IL IL166257A patent/IL166257A/en not_active IP Right Cessation
- 2005-03-01 NO NO20051089A patent/NO20051089L/no not_active Application Discontinuation
- 2005-06-29 HR HR20050605A patent/HRP20050605A2/hr not_active Application Discontinuation
-
2009
- 2009-04-20 US US12/426,730 patent/US20090203742A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| HRP20050605A2 (en) | 2006-02-28 |
| US20090203742A1 (en) | 2009-08-13 |
| EA200500298A1 (ru) | 2005-08-25 |
| MXPA05001275A (es) | 2005-04-28 |
| EA008594B1 (ru) | 2007-06-29 |
| BR0305717A (pt) | 2004-09-28 |
| IL166257A0 (en) | 2006-01-15 |
| NZ538488A (en) | 2007-10-26 |
| WO2004014371A1 (en) | 2004-02-19 |
| AU2003262561B2 (en) | 2008-10-16 |
| AU2003262561A1 (en) | 2004-02-25 |
| EP1545518A1 (en) | 2005-06-29 |
| AP2005003242A0 (en) | 2005-03-31 |
| CA2492832C (en) | 2012-05-22 |
| CN1671380B (zh) | 2010-05-26 |
| AP1878A (en) | 2008-08-13 |
| PL374948A1 (en) | 2005-11-14 |
| IL166257A (en) | 2013-04-30 |
| US20050267156A1 (en) | 2005-12-01 |
| CN1671380A (zh) | 2005-09-21 |
| KR20050025647A (ko) | 2005-03-14 |
| CA2492832A1 (en) | 2004-02-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20051089L (no) | Bredspektrede 2-amino-benzotiazol-sulfonamid-HIV-proteaseinhibitorer | |
| NO20051600L (no) | 1,4-disubstituerte piperidinderivater og anvendelse derav som 11-betaHSD1 inhibitorer | |
| NO20082629L (no) | Macrocyklisk factor VIIa-inhibitorer anvendbare som antikoagulanter | |
| NO20051965D0 (no) | Nye piperidinderivater for anvendelse ved behandling av kemokinmedierte sykdomstilstander. | |
| NO20071642L (no) | N-Benzensulfonylsubstituerte anilino-pyrimidinanaloger | |
| NO20054224L (no) | Nye 2-pyridinkarboksamidderivater | |
| DK1263722T3 (da) | Farmaceutiske sammensætninger, som indeholder azetidinderivat, nye azetidinderivater og fremstilling deraf | |
| DE60230266D1 (de) | Phenylpyridincarbonyl piperazinderivate | |
| DK1763534T3 (da) | Nye 2-substituerede D-homo-estra-1,3,5(10)-triener som inhibitorer af 17beta-hydroxysteroiddehydrogenasen type 1 | |
| NO20081074L (no) | Macrocyclisk inhibitorer av hepatitis C-virus | |
| DK1585739T3 (da) | Substituerede arylcyclopropylacetamider som glucokinaseaktivatorer | |
| NO20080789L (no) | 1,4-benzotiazepin 1,1-dioksidderivater, fremgangsmate for fremstilling derav, medikamenter inneholdende denne forbindelsen og anvendelse derav som et hypolipid | |
| NO20092279L (no) | Makrocyklisk factor VIIa inhibitorer anvendbare som antikoagulanter | |
| NO20054135L (no) | Kipolinon/benzoksazin derivater og anvendelser derav | |
| NO20052074L (no) | Substituerte benzoksazinoner og anvendelser derav. | |
| NO20062491L (no) | Benzoksazinderivter og deres anvendelse | |
| NO20071008L (no) | Fremgangsmate for fremstilling av N-piperidino-1,5-difenylpyrazol-3-karboksamidderivater | |
| NO20065902L (no) | 3-{4-(pyridin-3-yl)fenyl}-5-(1H-,1,2,3-triazol-1-ylmetyl)-1,3-oksazolidin-2-oner som antibakterielle midler | |
| AR045959A1 (es) | Derivados de pirazolo- e imidazo-pirimidina | |
| NO20060718L (no) | Substituerte tiofoner og deres anvendelse | |
| NO20071319L (no) | Fremgangsmate for fremstilling av isotiazolderivater. | |
| NO20060079L (no) | 6-(1,1-Difluoralkyl)-4-Aminopikolinater og deres anvendelse som Herbicider | |
| NO20063111L (no) | Fremgangsmate for fremstilling av tiazolpyrimidiner | |
| WO2008146919A1 (ja) | リンコサミド誘導体及びこれを有効成分とする抗菌剤 | |
| NO20082226L (no) | 6-heteroarylpyridoindolonderivater, deres fremstilling og terapeutisk anvendelse derav |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |